婴儿无晶状体治疗研究:10.5岁时眼球轴长增长
术眼术前及10.5岁时轴长均较短,但增长量无差异(4.7 mm,P=.99);接触镜组与人工晶状体组增长相似。合并青光眼或视力较差者眼球增长更多。
要点
- 术眼轴长在术前及10.5岁时均短于对侧眼,但增长量无显著差异(4.7 mm,P=.99)。
- 接触镜组与人工晶状体组轴长增长相似(P=.79),70.2%的增长发生在5岁前。
- 合并青光眼者眼轴增长(7.3 mm)显著多于无青光眼者(4.7 mm)及可疑青光眼者(5.1 mm)(P<.05)。
核心结论
- 单侧白内障术后术眼轴长增长与对侧未手术眼保持同步,人工晶状体与接触镜两组增长相似。
- 合并青光眼或视力较差(20/200或更差)的患眼往往比对侧眼增长更长。
研究设计与样本
- 婴儿无晶状体治疗研究(Infant Aphakia Treatment Study)的比较病例系列。
主要发现
- 术眼轴长术前较短(P<.0001)、10.5岁时仍较短(P=.021),但轴长增长量与对侧眼无差异(4.7 mm,P=.99)。
- 轴长增长的70.2%发生于5岁前、29.8%发生于5岁至10.5岁,接触镜组与人工晶状体组相似(P=.79)。
- 视力优于20/200者眼轴增长4.4 mm,视力20/200或更差者增长5.2 mm(P=.076)。
- 接受额外手术者眼轴增长多于未接受额外手术者(P=.052)。
- 青光眼患者眼轴增长7.3 mm,显著多于无青光眼者(4.7 mm)及可疑青光眼者(5.1 mm)(P<.05)。
关键数值与推荐
- 术眼与对侧眼轴长增长量比较:4.7 mm,P=.99。
- 轴长增长分布:5岁前占70.2%,5岁至10.5岁占29.8%。
- 视力优于20/200者增长4.4 mm,20/200或更差者增长5.2 mm(P=.076)。
- 青光眼者增长7.3 mm,无青光眼者4.7 mm,可疑青光眼者5.1 mm(P<.05)。
临床怎么用
- 单侧白内障术后应长期随访眼轴,尤其关注合并青光眼或视力较差者,其眼轴增长可能更快。
- 人工晶状体与接触镜矫正对眼轴增长的影响相似,选择矫正方式时可参考此结果。
局限性
- 原文未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the change in globe axial length (AL) from the time of unilateral cataract surgery at age 1-7 months to age 10.5 years for infants enrolled in the Infant Aphakia Treatment Study, and to compare AL growth of operated eyes with that of fellow unoperated eyes. DESIGN: Comparative case series. METHODS: AL growth was analyzed relative to treated vs fellow eye, contact lens (CL) vs intraocular lens (IOL), visual acuity (VA) outcome, and the need for surgery for visual axis opacification. Eyes with glaucoma or glaucoma suspect were excluded from the primary analysis but reported separately. RESULTS: Fifty-seven patients have reliable AL data available at both visits. AL was shorter in treated eyes preoperatively (P < .0001) and at 10.5 years of age (P = .021) but AL growth was not different (4.7 mm, P = .99). The growth (70.2% up to age 5 and 29.8% from age 5 to 10.5) was similar in the CL and the IOL group (P = .79). Eyes grew 4.4 mm when visual acuity (VA) was better than 20/200, and 5.2 mm when VA was 20/200 or worse (P = .076). Eyes receiving additional surgery grew more than eyes not receiving additional surgery (P = .052). Patients with glaucoma showed significantly more eye growth (7.3 mm) than those without glaucoma (4.7 mm) and glaucoma suspects (5.1 mm) (P < .05). CONCLUSIONS: Eyes with glaucoma or poor VA often grew longer than the fellow eye. Overall, treated eyes grew similarly in the IOL and CL groups and also kept pace with the growth of the fellow eyes.
引用
- Wilson ME, Trivedi RH, Weakley DR, et al. Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study. Am J Ophthalmol. 2020. PMID: 32304705. doi:10.1016/j.ajo.2020.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。